Trial intelligence / Profile preview

Letrozole plus PD 0332991 in Neoadjuvant Breast Cancer

NCT01709370Phase 2Unknown

Sponsor
Organisation for Oncology and Translational Research
Start
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of palbociclib in breast cancer, sponsored by Organisation for Oncology and Translational Research. Status: unknown.

02

Drugs

palbociclib
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01709370.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01709370.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call